Nanoparticles for controlled release of anti-biofilm agents and methods of use
    1.
    发明授权
    Nanoparticles for controlled release of anti-biofilm agents and methods of use 有权
    用于控制释放抗生物膜剂的纳米颗粒及其使用方法

    公开(公告)号:US09566247B2

    公开(公告)日:2017-02-14

    申请号:US14768945

    申请日:2014-02-25

    摘要: The present invention relates to compositions and methods to treat and/or prevent biofilms and biofilm related diseases. The invention comprises a nanoparticle carrier (NPC) and at least one therapeutic agent therein. The NPC binds within biofilm and to surfaces at risk for biofilm formation and accumulation while providing local, sustained, enhanced and controlled delivery of the therapeutic agent, when triggered for release. In one embodiment, the NPC comprises pH-responsive elements that allows for specific delivery of the therapeutic agent when the local environment dictates that the agent should be delivered precisely when it is most needed.

    摘要翻译: 本发明涉及治疗和/或预防生物膜和生物膜相关疾病的组合物和方法。 本发明包括纳米颗粒载体(NPC)和其中的至少一种治疗剂。 NPC在生物膜内和表面处于生物膜形成和积累的风险中,同时在触发释放时提供治疗剂的局部,持续,增强和控制的递送。 在一个实施方案中,NPC包含pH响应元件,其允许当局部环境指示当最需要时精细地递送药剂时特异性递送治疗剂。

    Nanoparticles for Controlled Release of Anti-Biofilm Agents and Methods of Use
    2.
    发明申请
    Nanoparticles for Controlled Release of Anti-Biofilm Agents and Methods of Use 审中-公开
    用于控制释放抗生物膜剂的纳米颗粒及其使用方法

    公开(公告)号:US20150374634A1

    公开(公告)日:2015-12-31

    申请号:US14768945

    申请日:2014-02-25

    摘要: The present invention relates to compositions and methods to treat and/or prevent biofilms and biofilm related diseases. The invention comprises a nanoparticle carrier (NPC) and at least one therapeutic agent therein. The NPC binds within biofilm and to surfaces at risk for biofilm formation and accumulation while providing local, sustained, enhanced and controlled delivery of the therapeutic agent, when triggered for release. In one embodiment, the NPC comprises pH-responsive elements that allows for specific delivery of the therapeutic agent when the local environment dictates that the agent should be delivered precisely when it is most needed.

    摘要翻译: 本发明涉及治疗和/或预防生物膜和生物膜相关疾病的组合物和方法。 本发明包括纳米颗粒载体(NPC)和其中的至少一种治疗剂。 NPC在生物膜内和表面处于生物膜形成和积累的风险中,同时在触发释放时提供治疗剂的局部,持续,增强和控制的递送。 在一个实施方案中,NPC包含pH响应元件,其允许当局部环境指示当最需要时精细地递送药剂时特异性递送治疗剂。

    Spin transistor using spin-orbit coupling induced magnetic field
    3.
    发明申请
    Spin transistor using spin-orbit coupling induced magnetic field 有权
    旋转晶体管采用自旋轨道耦合诱导磁场

    公开(公告)号:US20070059877A1

    公开(公告)日:2007-03-15

    申请号:US11305500

    申请日:2005-12-15

    IPC分类号: H01L21/8238

    摘要: A spin transistor having wide ON/OFF operation margin and producing less noise is provided. The spin transistor includes a substrate having a channel, a source, a drain and a gate formed on the substrate. The source and the drain are formed to have magnetization directions perpendicular to the length direction of the channel. The ON/OFF operations of the spin transistor can be controlled by generating a spin-orbit coupling induced magnetic field to have a direction parallel or anti-parallel to the magnetization directions of the source and the drain.

    摘要翻译: 提供具有宽的ON / OFF操作余量并产生较少噪声的自旋晶体管。 自旋晶体管包括具有在衬底上形成的沟道,源极,漏极和栅极的衬底。 源极和漏极形成为具有与沟道的长度方向垂直的磁化方向。 可以通过产生自旋轨道耦合感应磁场来使源极和漏极的磁化方向平行或反平行的方向来控制自旋晶体管的ON / OFF操作。